Refocus On China: Ark Bio Evolves As It Plans Shanghai Listing

Eyes R&D In Less Crowded Sectors

Poring Studio/Shutterstock.com
Ark Biosciences refocuses on hometurf, aiming for Shanghai IPO • Source: Shutterstock

More from China

More from Focus On Asia